Abu Dhabi – In support of the UAE’s voluntary National Vaccination Program, 2,573 of Khidmah employees based in the UAE have received their first of two COVID-19 vaccine doses. The leading facilities management and maintenance company said that another 579 employees are set to receive their inoculation by the end of January, bringing the total number of staff to partake in the National Vaccination Program to 98% from a total of 3,216 staff.

Abdellatif Sfaxi, CEO at Khidmah, said, “Our staff are leading by example and were quick to sign up for the Abu Dhabi government launched campaign ''Choose to Vaccinate'' out of their belief that together we are protected. We are proud of our team for taking part in this national drive that will save lives. We are also grateful to the UAE authorities for making the vaccine widely available to anyone who wants it to stay safe, stay protected and contribute to global efforts to combat the Pandemic.”

Khidmah staff have already been involved in the efforts to curb the spread of COVID-19 in the UAE since last year. In September 2020, 57 employees volunteered to participate in the initial COVID-19 vaccine Phase III trials launched by the government. Khidmah has also participated in the UAE Government’s National Sterilisation Programme, carrying out the disinfection of various streets, parks, and pathways around Abu Dhabi.

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.